Literature DB >> 1532662

T-cell responsiveness to an oncogenic peripheral protein and spontaneous autoimmunity in transgenic mice.

T Geiger1, L R Gooding, R A Flavell.   

Abstract

Why T cells develop autoimmune reactivity to some antigens and tolerance to others is unknown. Various mechanisms can provide for T-cell tolerance. These include deletion in the thymus, exhaustive differentiation in the periphery, T-cell receptor and coreceptor downregulation, and anergy. Which mechanisms normally provide for tolerance to antigens expressed on specific tissues and why they sometimes fail is unclear. To understand this, we analyzed how a tissue-specific protein with defined timing and location of expression is recognized by T cells so as to induce tolerance or autoimmunity. We crossed mice expressing the simian virus 40 large tumor antigen on pancreatic acini beginning 4-25 days after birth with mice transgenic for a rearranged T-cell receptor that recognizes this antigen presented by the class I major histocompatibility complex molecule H-2Kk. No T-cell tolerance was found; rather, T-cell reactivity accompanied lymphocytic infiltration and pancreatic acinar destruction. This result argues that T cells may become spontaneously autoreactive to certain postnatally expressed peripheral proteins and that this reactivity may lead to autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532662      PMCID: PMC48788          DOI: 10.1073/pnas.89.7.2985

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Transgenic mouse models of self-tolerance and autoreactivity by the immune system.

Authors:  D Hanahan
Journal:  Annu Rev Cell Biol       Date:  1990

2.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.

Authors:  H Pircher; K Bürki; R Lang; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

3.  Fine mapping of an H-2Kk restricted cytotoxic T lymphocyte epitope in SV40 T antigen by using in-frame deletion mutants and a synthetic peptide.

Authors:  F C Rawle; K A O'Connell; R W Geib; B Roberts; L R Gooding
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

4.  Tolerance of class I histocompatibility antigens expressed extrathymically.

Authors:  G Morahan; J Allison; J F Miller
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

Review 5.  Veto cells.

Authors:  P J Fink; R P Shimonkevitz; M J Bevan
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

6.  T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E.

Authors:  L C Burkly; D Lo; O Kanagawa; R L Brinster; R A Flavell
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

7.  Peripheral tolerance to allogeneic class II histocompatibility antigens expressed in transgenic mice: evidence against a clonal-deletion mechanism.

Authors:  K M Murphy; C T Weaver; M Elish; P M Allen; D Y Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant.

Authors:  J Böhme; K Haskins; P Stecha; W van Ewijk; M LeMeur; P Gerlinger; C Benoist; D Mathis
Journal:  Science       Date:  1989-06-09       Impact factor: 47.728

9.  Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter.

Authors:  G Morahan; F E Brennan; P S Bhathal; J Allison; K O Cox; J F Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells.

Authors:  D Lo; L C Burkly; R A Flavell; R D Palmiter; R L Brinster
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Death and destruction of activated T lymphocytes.

Authors:  I N Crispe
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance.

Authors:  Maria Papatriantafyllou; Gerhard Moldenhauer; Julia Ludwig; Anna Tafuri; Natalio Garbi; Gorana Hollmann; Günter Küblbeck; Alexandra Klevenz; Sabine Schmitt; Georg Pougialis; Christof Niehrs; Hermann-Josef Gröne; Gunter J Hämmerling; Bernd Arnold; Thilo Oelert
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen.

Authors:  Roland Reibke; Natalio Garbi; Ruth Ganss; Günter J Hämmerling; Bernd Arnold; Thilo Oelert
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-28       Impact factor: 11.205

Review 4.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

Authors:  C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

5.  Regulation of AP-1 and NFAT transcription factors during thymic selection of T cells.

Authors:  M Rincon; R A Flavell
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

Review 6.  Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii.

Authors:  Matthew S Gentry; Carlos Romá-Mateo; Pascual Sanz
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

7.  Cellular and molecular requirements for the selection of in vitro-generated CD8 T cells reveal a role for Notch.

Authors:  Dzana D Dervovic; Haydn C-Y Liang; Jennifer L Cannons; Alisha R Elford; Mahmood Mohtashami; Pamela S Ohashi; Pamela L Schwartzberg; Juan Carlos Zúñiga-Pflücker
Journal:  J Immunol       Date:  2013-07-12       Impact factor: 5.422

8.  B7 blockade alters the balance between regulatory T cells and tumor-reactive T cells for immunotherapy of cancer.

Authors:  Penghui Zhou; Xincheng Zheng; Huiming Zhang; Yang Liu; Pan Zheng
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

9.  In vivo tolerance breakdown with dendritic cells pulsed with U1A protein in non-autoimmune mice: the induction of a high level of autoantibodies but not renal pathological changes.

Authors:  Jau-Ling Suen; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

10.  Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells.

Authors:  Kimberly A Shafer-Weaver; Stephanie K Watkins; Michael J Anderson; Lauren J Draper; Anatoli Malyguine; W Gregory Alvord; Norman M Greenberg; Arthur A Hurwitz
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.